medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»medalphabet-627Research ArticleКОЛОНКА ГЛАВНОГО РЕДАКТОРАВозможности современной стресс-эхокардиографии при митральных порокахClinical use of modern stress echocardiography in mitral valve diseasesБартош-ЗеленаяС. Ю.Bartosh-ZelenayaS. J.noemail@neicon.ruНайденТ. В.NaidenT. V.noemail@neicon.ruШпыноваИ. А.ShpynovaI. A.noemail@neicon.ruКовалеваН. Н.KovalevaN. N.noemail@neicon.ruФГБОУ ВО «Северо-Западный Государственный медицинский университет им. И. И. Мечникова»РоссияNorth-Western State Medical University named after I. I. MechnikovRussian FederationООО «Медика»РоссияMedica CompanyRussian Federation201807052018114Современная функциональная диагностика3844Copyright © Бартош-Зеленая С.Ю., Найден Т.В., Шпынова И.А., Ковалева Н.Н., 20182018Бартош-Зеленая С.Ю., Найден Т.В., Шпынова И.А., Ковалева Н.Н.Bartosh-Zelenaya S.J., Naiden T.V., Shpynova I.A., Kovaleva N.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/627

В настоящем обзоре рассматриваются возможности стресс-эхокардиографии (стресс-ЭхоКГ) с физической или фармакологической нагрузкой при митральных пороках. Рассматриваются вопросы клинического ухудшения и необходимости оперативного лечения при митральном стенозе. Обсуждаются клинические показания к проведению теста при первичной и вторичной митральной недостаточности. Приведены клинические и гемодинамические параметры, рекомендованные для оценки, а также принципы интерпретации результатов, стратификации риска и отбора больных для хирургического лечения на основании стресс-теста.

Current review contains data concerning the role of exercise or dobutamine stress echocardiography (stress-echo) in mitral valve diseases. Challenges of clinical impairment and necessity of surgical treatment in mitral stenosis are discussed. The clinical indications for stress testing are proposed. Clinical and hemodynamic parameters for stress-echo assessment are presented. The principles of test result interpretation, risk stratification and selection of patients for surgical treatment, based on stress-echo data, are summarized.

стресс-эхокардиографиямитральный стенозмитральная недостаточностьконтрактильный резервstress echocardiographymitral stenosismitral insufficiencycontractile reserveReferencesCoisne A., Levy F., Malaquin D. et al. Feasibility of Doppler hemodynamic evaluation of primary and secondary mitral regurgitation during exercise echocardiography. International Journal of Cardiovascular Imaging. 2015; 31:291-299.Coisne A., Levy F., Malaquin D. et al. Feasibility of Doppler hemodynamic evaluation of primary and secondary mitral regurgitation during exercise echocardiography. International Journal of Cardiovascular Imaging. 2015; 31:291-299.Garbi M., Chambers J., Vannan M.A., Lancellotti P. Valve stress echocardiography: a practical guide for referral, procedure, reporting, and clinical implementation of results from the HAVEC Group. Journal of American College of Cardiology: Cardiovascular Imaging. 2015; 8: 724-736.Garbi M., Chambers J., Vannan M.A., Lancellotti P. Valve stress echocardiography: a practical guide for referral, procedure, reporting, and clinical implementation of results from the HAVEC Group. Journal of American College of Cardiology: Cardiovascular Imaging. 2015; 8: 724-736.Lancellotti P., Fattouch K, La Canna G. Therapeutic decision-making for patients with fluctuating mitral regurgitation. Nature Reviews Cardiology. 2015; 12: 212-219.Lancellotti P., Fattouch K, La Canna G. Therapeutic decision-making for patients with fluctuating mitral regurgitation. Nature Reviews Cardiology. 2015; 12: 212-219.Lancellotti P., Magne J., Dulgheru R., Ancion A. et al. Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. American Journal of Cardiology. 2015; 115:1454-1461.Lancellotti P., Magne J., Dulgheru R., Ancion A. et al. Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. American Journal of Cardiology. 2015; 115:1454-1461.Lancellotti P., Pellikka P. A., Budts W. EACVI/ ASE clinical recommendations. The use of stress echocardiography in non-ischaemic heart disease. Journal of American Society of Echocardiography. 2017; 30: 101-138.Lancellotti P., Pellikka P. A., Budts W. EACVI/ ASE clinical recommendations. The use of stress echocardiography in non-ischaemic heart disease. Journal of American Society of Echocardiography. 2017; 30: 101-138.Magne J., Mahjoub H., Dulgheru R. et al. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. European Heart Journal. 2014; 35:1608-1616.Magne J., Mahjoub H., Dulgheru R. et al. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. European Heart Journal. 2014; 35:1608-1616.Magne J., Pibarot P., Sengupta P. P. et al. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. Journal of American College of Cardiology: Cardiovascular Imaging. 2015; 8:83-99.Magne J., Pibarot P., Sengupta P. P. et al. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. Journal of American College of Cardiology: Cardiovascular Imaging. 2015; 8:83-99.Naji P., Griffin B. P., Asfahan F. et al. Predictors of long-term outcomes in patients with significant myxomatous mitral regurgitation undergoing exercise echocardiography. Circulation. 2014; 129:1310-1319.Naji P., Griffin B. P., Asfahan F. et al. Predictors of long-term outcomes in patients with significant myxomatous mitral regurgitation undergoing exercise echocardiography. Circulation. 2014; 129:1310-1319.Nishimura R. A., Otto C. M., Sorajja P. et al. AHA/ACC Guideline for the management of patients with valvular heart disease. Circulation. 2014; 129(23):2441-2488.Nishimura R. A., Otto C. M., Sorajja P. et al. AHA/ACC Guideline for the management of patients with valvular heart disease. Circulation. 2014; 129(23):2441-2488.Nishimura R.A., Otto C.M., Bonow R. O. et al. AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of American College of Cardiology. 2017; 70(2): 254-289.Nishimura R.A., Otto C.M., Bonow R. O. et al. AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of American College of Cardiology. 2017; 70(2): 254-289.Vahanian A., Alfiery O., Andreotti F. et al. ESC/EACTS Guidelines on the management of valvular heart disease. European Heart Journal. 2012; 33(19): 2451-2496.Vahanian A., Alfiery O., Andreotti F. et al. ESC/EACTS Guidelines on the management of valvular heart disease. European Heart Journal. 2012; 33(19): 2451-2496.

The authors declare that there are no conflicts of interest present.